The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia
Michael Byrne(Vanderbilt University Medical Center), Michael R. Savona(Vanderbilt University), Stephen A. Strickland(Vanderbilt University), Reena Jayani(Vanderbilt University Medical Center), Stacey Goodman(Texas Oncology), Adetola A. Kassim(Vanderbilt University), Sanjay Mohan(Breast Cancer Research Foundation), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Kristin Fogo(Vanderbilt University Medical Center), Madan Jagasia(Vanderbilt University Medical Center), Adrianne Rasche(Vanderbilt University Medical Center), Wichai Chinratanalab(VA Tennessee Valley Healthcare System), Katie Culos(Vanderbilt University Medical Center), Houston Wyatt(Vanderbilt University Medical Center), Katie S. Gatwood(Vanderbilt University Medical Center), Salyka Sengsayadeth(VA Tennessee Valley Healthcare System), P. Brent Ferrell(Vanderbilt University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Nathalie Danielson(VA Tennessee Valley Healthcare System)
Cited by 80
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655